AGC Biologics names Kasper Moller new chief technical officer.

M2 PHARMA-June 5, 2019-AGC Biologics names Kasper Moller new chief technical officer

(C)2019 M2 COMMUNICATIONS

AGC Biologics, a global company involved in clinical and commercial development and manufacturing of therapeutic proteins, announced yesterday that it has named Kasper Moller as its new chief technical officer.

Moller will report to Patricio Massera, chief executive officer.

Moller joined AGC Biologics in 2006 as a scientist at the Copenhagen facility and has held the positions of principal scientist (2007) and department manager (2008) within Process Development. Beginning in 2010, Kasper led the Upstream Process Development teams and in 2011, he led process characterisation and validation activities. In 2013 - 2014, Kasper was appointed vice president of Process Development and in 2014 - 2017, Kasper was appointed vice president of Manufacturing. He has most recently served as the site head for AGC Biologics' Copenhagen facility and his role was expanded to include oversight of the Heidelberg, Germany site as well as Global Supply Chain Management and Global IT.

((Comments on this story may be sent to info@m2.com))